GlaxoSmithKline PLC — Director's Dealing 2014

Jan 3, 2014

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8545W

GlaxoSmithKline PLC

03 January 2014

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.07 per Ordinary Share, and notional ADSs at a price of $53.17 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2013 to 31 December 2013:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,644.680
Professor Sir Roy Anderson	563.939
Dr Stephanie Burns		320.928
Stacey Cartwright	447.262
Lynn  Elsenhans		577.671
Judy Lewent		311.489
Sir Deryck Maughan		868.394
Dr Daniel Podolsky		651.295
Tom de Swaan	408.370
Jing Ulrich		217.098
Hans Wijers	447.262
Sir Robert Wilson	447.262

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2014.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

Sonja Arsenić 

Corporate Secretariat

3 January 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSKXLBBZFFXBBD